Approval · Notice of Compliance 4924 · 1995
DOVONEX: Notice of Compliance 4924
Issued November 15, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4924
- Date
- November 15, 1995
- Company
- Leo Laboratories Canada Ltd.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosge form: scalp solution
- Therapeutic class
- Non-steroidal antipsoriatic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOVONEX | 02194341 | Cancelled Post Market |
Medicinal ingredients
- CALCIPOTRIOL 50 MCG per ML